BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38049635)

  • 1. Five special focuses of Hypertension Research: digital hypertension, home blood pressure-centered approach, renal denervation, Asians, for guidelines.
    Kario K; Hoshide S; Mogi M
    Hypertens Res; 2023 Dec; 46(12):2557-2560. PubMed ID: 38049635
    [No Abstract]   [Full Text] [Related]  

  • 2. A Japan nationwide web-based survey of patient preference for renal denervation for hypertension treatment.
    Kario K; Kagitani H; Hayashi S; Hanamura S; Ozawa K; Kanegae H
    Hypertens Res; 2022 Feb; 45(2):232-240. PubMed ID: 34657136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Ongoing Odyssey of Renal Denervation.
    Vinayak M; Olin JW; Stone GW
    J Am Coll Cardiol; 2023 Nov; 82(19):1824-1827. PubMed ID: 37914511
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal denervation for the treatment of resistant hypertension in Spain. The Flex-Spyral Registry.
    Rodriguez-Leor O; Segura J; García Donaire JA; Gutiérrez-Ibañes E; Oliveras A; Mediavilla JD; Serrador A; Prado JC; Nuñez-Gil I; Díez-Delhoyo F; Clarà Velasco A; Jaén Águila F; Amat-Santos I; Bayes-Genis A; Troya Saborido MI
    Rev Esp Cardiol (Engl Ed); 2020 Aug; 73(8):615-622. PubMed ID: 31561981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to Antihypertensive Treatment and the Blood Pressure-Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial.
    Azizi M; Pereira H; Hamdidouche I; Gosse P; Monge M; Bobrie G; Delsart P; Mounier-Véhier C; Courand PY; Lantelme P; Denolle T; Dourmap-Collas C; Girerd X; Michel Halimi J; Zannad F; Ormezzano O; Vaïsse B; Herpin D; Ribstein J; Chamontin B; Mourad JJ; Ferrari E; Plouin PF; Jullien V; Sapoval M; Chatellier G;
    Circulation; 2016 Sep; 134(12):847-57. PubMed ID: 27576780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial.
    Mahfoud F; Kandzari DE; Kario K; Townsend RR; Weber MA; Schmieder RE; Tsioufis K; Pocock S; Dimitriadis K; Choi JW; East C; D'Souza R; Sharp ASP; Ewen S; Walton A; Hopper I; Brar S; McKenna P; Fahy M; Böhm M
    Lancet; 2022 Apr; 399(10333):1401-1410. PubMed ID: 35390320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twenty-Four-Hour Blood Pressure Monitoring to Predict and Assess Impact of Renal Denervation: The DENERHTN Study (Renal Denervation for Hypertension).
    Gosse P; Cremer A; Pereira H; Bobrie G; Chatellier G; Chamontin B; Courand PY; Delsart P; Denolle T; Dourmap C; Ferrari E; Girerd X; Michel Halimi J; Herpin D; Lantelme P; Monge M; Mounier-Vehier C; Mourad JJ; Ormezzano O; Ribstein J; Rossignol P; Sapoval M; Vaïsse B; Zannad F; Azizi M
    Hypertension; 2017 Mar; 69(3):494-500. PubMed ID: 28115517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of renal denervation on blood pressures in patients with hypertension: a systematic review and meta-analysis of randomized sham-controlled trials.
    Ogoyama Y; Tada K; Abe M; Nanto S; Shibata H; Mukoyama M; Kai H; Arima H; Kario K
    Hypertens Res; 2022 Feb; 45(2):210-220. PubMed ID: 34657140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis.
    Ewen S; Meyer MR; Cremers B; Laufs U; Helfer AG; Linz D; Kindermann I; Ukena C; Burnier M; Wagenpfeil S; Maurer HH; Böhm M; Mahfoud F
    Clin Res Cardiol; 2015 Dec; 104(12):1097-105. PubMed ID: 26306594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In hypertension not treated with medications, renal denervation vs. sham reduced daytime ambulatory SBP at 2 mo.
    Samuels JA; Molony DA
    Ann Intern Med; 2023 Jun; 176(6):JC68. PubMed ID: 37276593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of renal denervation for the management of arterial hypertension: A systematic review and meta-analysis of randomized, sham-controlled, catheter-based trials.
    Stavropoulos K; Patoulias D; Imprialos K; Doumas M; Katsimardou A; Dimitriadis K; Tsioufis C; Papademetriou V
    J Clin Hypertens (Greenwich); 2020 Apr; 22(4):572-584. PubMed ID: 32049436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consensus and inconsistency between different consensus documents on renal denervation worldwide: the way forward.
    Wang TD
    Chin Med J (Engl); 2022 Dec; 135(24):2926-2937. PubMed ID: 36103983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of renal sympathetic denervation in hypertension.
    Lateef N; Virk HU; Khan MS; Lakhter V; Haseeb A; Ahsan MJ; Mirza M; Rangaswami J; Zidar DA; Holmberg M; Janzer S
    Future Cardiol; 2020 Jul; 16(4):211-216. PubMed ID: 32166965
    [No Abstract]   [Full Text] [Related]  

  • 14. Catheter-based renal denervation in Chinese patients with chronic kidney disease and uncontrolled hypertension.
    Liu S; Bian R; Qian Y; Liao H; Gao X; Zhang Y; Dong W
    J Clin Hypertens (Greenwich); 2023 Jan; 25(1):71-77. PubMed ID: 36478498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transurethral Renal Pelvic Denervation: A Feasibility Trial in Patients with Uncontrolled Hypertension.
    Hering D; Nikoleishvili D; Imedadze A; Dughashvili G; Klimiashvili Z; Bekaia E; Shengelia T; Kobalava M; Goguadze O; Emukhvari T; Druker V; Sackner-Bernstein J; Weber MA
    Hypertension; 2022 Dec; 79(12):2787-2795. PubMed ID: 36254733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of patients undergoing renal sympathetic denervation.
    Zeijen VJM; Feyz L; Nannan Panday R; Veen K; Versmissen J; Kardys I; Van Mieghem NM; Daemen J
    Clin Res Cardiol; 2022 Nov; 111(11):1256-1268. PubMed ID: 35851428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized comparison of renal denervation versus intensified pharmacotherapy including spironolactone in true-resistant hypertension: six-month results from the Prague-15 study.
    Rosa J; Widimský P; Toušek P; Petrák O; Čurila K; Waldauf P; Bednář F; Zelinka T; Holaj R; Štrauch B; Šomlóová Z; Táborský M; Václavík J; Kociánová E; Branny M; Nykl I; Jiravský O; Widimský J
    Hypertension; 2015 Feb; 65(2):407-13. PubMed ID: 25421981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal Denervation for Hypertension: A Systematic Review and Meta-Analysis of Randomized, Blinded, Placebo-Controlled Trials.
    Ahmad Y; Francis DP; Bhatt DL; Howard JP
    JACC Cardiovasc Interv; 2021 Dec; 14(23):2614-2624. PubMed ID: 34743900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perfect 24-hr Blood Pressure Control: Up-to-Date 2020.
    Kario K
    Curr Hypertens Rev; 2020; 16(1):2-10. PubMed ID: 32065084
    [No Abstract]   [Full Text] [Related]  

  • 20. Transradial renal denervation for the treatment of resistant hypertension.
    Dong H; Jiang X; Liang T; Zou Y; Guan T; Peng M; Song L; Zhang H; Wu H; Xu B; Yang Y; Gao R
    J Invasive Cardiol; 2014 Jul; 26(7):322-7. PubMed ID: 24993989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.